Abiopharma

🔍 JEFFS ROGER (Director)

Company: Liquidia Corp (LQDA)

Report Date: 2026-04-17

Detailed Transactions and Holdings:

• Sold 18,839 shares of Common Stock at $40.6049 per share (Direct)
  Date: 2026-04-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,423,095.00 | transaction_form_type: 4 | Footnotes: F3, F4, F5
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-17 | Code: H | shares_owned_after: 1,137,599.00 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-17 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 46,595.00 | Footnotes: F2

Footnotes:

• F1: Includes (i) 54,281 unvested restricted stock units ("RSUs") of the 289,500 RSUs granted to the Reporting Person on January 11, 2023, (ii) 96,835 unvested RSUs of the 221,338 RSUs granted to the Reporting Person on January 11, 2024, (iii) 157,662 unvested RSUs of the 229,327 RSUs granted to the Reporting Person on January 11, 2025 and (iv) 115,344 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4.
• F2: The securities are held by Roger A. Jeffs Living Trust UAD 2/29/2000 (the "Trust"). The Reporting Person is the trustee of the Trust.
• F3: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025.
• F4: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $40.00 to $41.85. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F5: The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity.